Skip to main content

Advertisement

Log in

ASO Author Reflections: Refining Radiotherapy Decisions in T3N0M0 Breast Cancer: A Nomogram-Based Approach

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Taghian AG, Jeong JH, Mamounas EP, et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. J Clin Oncol. 2006;24(24):3927–32. https://doi.org/10.1200/jco.2006.06.9054.

    Article  PubMed  Google Scholar 

  2. Floyd SR, Taghian AG. Post-mastectomy radiation in large node-negative breast tumors: does size really matter? Radiother Oncol. 2009;91(1):33–7. https://doi.org/10.1016/j.radonc.2008.09.015.

    Article  PubMed  Google Scholar 

  3. Jwa E, Shin KH, Lim HW, et al. Identification of risk factors for locoregional recurrence in breast cancer patients with nodal stage N0 and N1: who could benefit from post-mastectomy radiotherapy? PLoS One. 2015;10(12):e0145463. https://doi.org/10.1371/journal.pone.0145463.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wu SG, Wang J, Lei J, et al. Prognostic validation and therapeutic decision-making of the AJCC eighth pathological prognostic staging for T3N0 breast cancer after mastectomy. Clin Transl Med. 2020;10(1):125–36. https://doi.org/10.1002/ctm2.3.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Meng X, Wang N, Qin P, Jia Q, Ju Z, Jiang Y. Nomogram-based risk stratification to identify T3N0M0 breast cancer patients with survival benefit from post-mastectomy radiotherapy. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14723-6.

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Development Project in Science and Technology of Weifang (Soft Science) (Weifang Science and Technology Bureau, Grant Number: 2022RKX015).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yingxiao Jiang MM.

Ethics declarations

Disclosures

The authors have no relevant financial or nonfinancial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article refers to: Meng X, Wang N, Qin P, Jia Q, Ju Z, Jiang Y. Nomogram-based risk stratification to identify T3N0M0 breast cancer patients with survival benefit from post-mastectomy radiotherapy. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14723-6.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Meng, X., Wang, N., Qin, P. et al. ASO Author Reflections: Refining Radiotherapy Decisions in T3N0M0 Breast Cancer: A Nomogram-Based Approach. Ann Surg Oncol 31, 2274–2275 (2024). https://doi.org/10.1245/s10434-023-14818-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14818-0

Navigation